DUCIME, ALEX
 Distribuzione geografica
Continente #
NA - Nord America 706
EU - Europa 420
AS - Asia 149
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.280
Nazione #
US - Stati Uniti d'America 695
IT - Italia 125
DE - Germania 66
CN - Cina 57
IE - Irlanda 45
SG - Singapore 44
FR - Francia 41
SE - Svezia 37
FI - Finlandia 30
AT - Austria 29
KR - Corea 13
GB - Regno Unito 11
IN - India 11
CA - Canada 10
BE - Belgio 8
PL - Polonia 7
UA - Ucraina 7
VN - Vietnam 6
MY - Malesia 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
SN - Senegal 4
HK - Hong Kong 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
GE - Georgia 2
NL - Olanda 2
PT - Portogallo 2
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
MK - Macedonia 1
MX - Messico 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.280
Città #
Chandler 84
Ann Arbor 80
Houston 62
Dublin 45
Singapore 35
Torino 35
Woodbridge 35
Beijing 29
Vienna 29
Villeurbanne 29
Dearborn 28
Fairfield 22
Jacksonville 20
Wilmington 20
Ashburn 19
Medford 19
Nyköping 17
Munich 16
Cambridge 14
Columbus 14
Pisa 14
Princeton 14
Seattle 12
Fremont 11
Brussels 8
Milan 8
Siena 8
Turin 8
Warsaw 6
Boston 5
Leinì 5
Ottawa 5
Santa Clara 5
Boardman 4
Hangzhou 4
Hefei 4
Jakarta 4
Norwalk 4
Segrate 4
Toronto 4
Arlington 3
Dong Ket 3
Düsseldorf 3
Kuala Lumpur 3
Nanjing 3
Rivoli 3
Ahmedabad 2
Al Ain City 2
Batu Caves 2
Cuneo 2
Ellicott City 2
Guangzhou 2
Gunzenhausen 2
Kunming 2
Leawood 2
Mapo-gu 2
New Orleans 2
Nürnberg 2
Piemonte 2
Pune 2
Rome 2
Shanghai 2
Albinea 1
Bangalore 1
Basel 1
Bursa 1
Central District 1
Changchun 1
Cleveland 1
Dallas 1
Gainesville 1
Gammertingen 1
Helsinki 1
Iserlohn 1
Jinan 1
La Canada Flintridge 1
Malmö 1
Mexico 1
Montigny-le-bretonneux 1
Montreal 1
Mumbai 1
Nanchang 1
Oakland 1
Phoenix 1
Pietrasanta 1
Quzhou 1
Radomsko 1
Redmond 1
Redwood City 1
San Diego 1
San Mateo 1
Sofia 1
Stroppiana 1
Taizhou 1
Tappahannock 1
Urbino 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 876
Nome #
Substituted 4-hydroxy-1,2,3-triazoles: synthesis, characterization and first drug design applications through bioisosteric modulation and scaffold hopping approaches 170
N-Acetyl-3-aminopyrazoles block the non canonical NF-kB cascade by selectively inhibiting NIK 125
PROBING THE BICYCLIC HYDROXYPYRAZOLO[1,5-a]PYRIDINE SCAFFOLD AS A CARBOXYLIC ACID BIOISOSTERE IN THE GABAa RECEPTOR SYSTEM 123
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade 117
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors 113
TOWARD A BIOISOSTERIC ALKAEST – APPLICATION TO THE BIOISOSTERIC MODULATION OF IMD-0354 106
Towards a Bioisosteric Alkaest: application to the bioisosteric modulation of IMD-0354 96
Discovery and optimization of new OvCHT1 inhibitors based on the 4-hydroxy-1H-1,2,3-triazole ring 87
Synthesis and Structural Characterization of Regio Substituted 4-Hydroxy-1H-1,2,3-triazols as Possible Tool in Bioisosteric Applications 80
SUBSTITUTED 4-HYDROXY-1H-1,2,3-TRIAZOLES: SYNTHESIS AND BIOISOSTERIC APPLICATIONS 70
Probing the bicyclic hydroxypyrazolo[1,5-a]pyridine scaffold as a carboxylic acid bioisostere in theGABAA receptor system 65
Regioselective N‐Alkylation of Ethyl 4‐Benzyloxy‐1,2,3‐triazolecarboxylate: A Useful Tool for the Synthesis of Carboxylic Acid Bioisosteres 61
Hydroxypyrazolo[1,5-a]pyridine as a fluorescent carboxylic acid isostere: introducing GABAA receptor system affinities in the scaffold 55
Hydroxypyrazolo[1,5-a]pyridine as a fluorescent carboxylic acid isostere: probing first MedChem bioisosteric applications 50
Totale 1.318
Categoria #
all - tutte 3.670
article - articoli 0
book - libri 0
conference - conferenze 2.065
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 0 0 0 0 11 64 22 5 5 17 10 8
2020/2021136 18 15 5 10 12 1 11 7 23 18 4 12
2021/2022177 13 1 4 18 16 10 7 5 3 13 57 30
2022/2023234 23 14 12 30 24 53 22 13 24 2 8 9
2023/202493 20 26 7 8 2 10 0 0 0 5 2 13
2024/202582 0 28 9 28 17 0 0 0 0 0 0 0
Totale 1.318